[Clinical observations of lenalidomide combination chemotherapy for relapsing or refractory multiple myeloma].
Li X, Sun W, An N, Huang Z, Chen S, Shen M, Zhong Y, Zhang J, Hu Y, Zhan X.
Li X, et al. Among authors: an n.
Zhonghua Yi Xue Za Zhi. 2015 Mar 17;95(10):745-8.
Zhonghua Yi Xue Za Zhi. 2015.
PMID: 26080845
Chinese.
The regimens were RD (lenalidomide and dexamethasone, n = 6), RCD (lenalidomide, ifosfamide and dexamethasone, n = 4), RDD (lenalidomide, liposomal doxorubicinand dexamethasone, n = 1), PRD (lenalidomide, velcade and dexamethasone, n = 1) and R+DECP (l …
The regimens were RD (lenalidomide and dexamethasone, n = 6), RCD (lenalidomide, ifosfamide and dexamethasone, n = 4), RDD (le …